The optimal management of CKD-MBD in dialysis patients

The optimal management for osteoporosis in terms of CKD-MBD in dialysis patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0004542

Enrollment

900

Registered

2019-12-12

Start date

2019-12-01

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Radiation : * Bone Densitometry (DEXA,femur, spine): at 0, 24 months * T-L spine AP & lateral, L-S spine lateral x-ray: at 0, 24 months

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Inclusion criteria - Adults more than 19 years old - CKD stage 5D patients receiving hemodialysis or peritoneal dialysis more than 3 months

Exclusion criteria

Exclusion criteria: 2. Exclusion criteria - Hospitalized patients - Patients who were diagnosed malignancy within 5 years - Patients who were previously diagnosed and treated osteoporosis - Patients who are currently treated osteoporosis - Patients with history of osteoporotic fracture - Patients who were diagnosed cardiovascular, cerebrovascular, and peripheral artery diseases within 6 months - Patients who were treated steroid and immunosuppressive agents within 6 months - Patients who are not suitable for this study

Design outcomes

Primary

Measure	Time frame
The incidence of fracture, development of MACE	—

Secondary

Measure	Time frame
Hospitalization of cardiovascular disease, the incidence of PCI	—

Countries

Korea, Republic of

Contacts

Public ContactYu Ah Hong

The Catholic University of Korea, Daejeon St. Mary's Hospital

amorfati00@gmail.com+82-42-220-9114

Outcome results